Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICRO-CART: LBP + CAR-T for B-Cell Lymphoma and Multiple Myeloma
NCT07871747Phase 1Not yet recruiting
- Sponsor
- University of Chicago
- Start
- Feb 2027
- Primary completion
- Sep 2030
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in B cell lymphoma and multiple myeloma (MM) (2 arms), sponsored by University of Chicago. Primary endpoint: Safety and tolerability at 24 months. Planned start Feb 2027; status: not yet recruiting.
02
Conditions
B cell lymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on NCT07871747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07871747.